TearSolutions
PrivateLast Round
Series B
Nov 21, 2024
Total Funding Raised
$14.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TearSolutions is a biotechnology company that develops topical therapeutics for the treatment of dry eye disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TearSolutions Comparables
Compare TearSolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stuart Therapeutics, Inc. | 85% | |
| Claris Bio | 80% | |
| RegeneRx Biopharmaceuticals, Inc. | 79% | |
TearSolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 21, 2024 | ||||
| Series B | Dec 7, 2017 | ||||
| Series A | Nov 4, 2015 |
Key People
Founding team and executive leadership
TearSolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Virginia Innovation Partnership Corporation | Series A |
| Pharmstandard International S.A. | Series B |
| Launch Capital | Series A |
| Santen Ventures | Series B |
| VTC Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 52% MoM.
- May 16, 2026
Monthly visitors increased 31% MoM.
TearSolutions Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TearSolutions's valuation, stock price, and market status.